Test Price
2,800 AED✅ Home Collection Available
KLF8 Gene Non-Syndromic Intellectual Disability Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين KLF8 المرتبط بالتخلف العقلي غير المتلازمي بتقنية التسلسل الجيني من الجيل التالي (NGS) في الإمارات | ٢٨٠٠ درهم | معتمد من هيئة الصحة بدبي ٢٠٢٦
DHA-APPROVED Executive Summary — ملخص تنفيذي
- ✓ Diagnostic Accuracy Guarantee: 99.9% Analytical Sensitivity & Specificity via ISO 9001:2015 Certified NGS Processing — دقة تشخيصية مضمونة بنسبة ٩٩.٩٪ عبر تقنية التسلسل الجيني من الجيل التالي المعتمدة وفق معيار الأيزو.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Transport & VIP Mobile Phlebotomy (8 AM – 11 PM Daily) — خدمة سحب منزلي فاخرة ومعتمدة بنقل مبرّد طبي.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Correlation & Result Interpretation by DHA-Licensed Consultants — استشارة طبية هاتفية ما بعد النتيجة مع أطباء مرخصين من هيئة الصحة بدبي.
- ✓ Insurance & Billing: Direct Billing Verification via WhatsApp — تحقق مباشر من تغطية التأمين الصحي عبر واتساب.
- 📞 Immediate Support — الدعم الفوري: +971 54 548 8731
Overview — نظرة عامة
The KLF8 Gene Non-Syndromic Intellectual Disability Genetic Test is a high-resolution molecular diagnostic assay designed to detect pathogenic variants in the KLF8 gene (Krüppel-Like Factor 8) associated with autosomal non-syndromic intellectual disability. This test utilises Next Generation Sequencing (NGS) technology to deliver comprehensive coding-region coverage with unparalleled nucleotide-level resolution. يُعد هذا التحليل الجيني المتقدم أداة تشخيصية دقيقة للكشف عن الطفرات المسببة للتخلف العقلي غير المتلازمي المرتبط بالجين KLF8، ويُجرى وفق أعلى المعايير التقنية المعتمدة من هيئة الصحة بدبي.
| Parameter | Our KLF8 NGS Test — فحصنا | Closest Alternative (Conventional Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% Single-Nucleotide Resolution (NGS) | ~98% Targeted Exon-Only Coverage |
| Methodology | Next Generation Sequencing (NGS) — High-Throughput Parallel Sequencing | Sanger Sequencing (Low Throughput, Single Amplicon) |
| Turnaround Time | 21–28 Working Days (Comprehensive Bioinformatic Analysis) | 14–21 Days (Limited Analytical Depth) |
| Coverage | Full Gene: Coding Exons, Splice Junctions, UTR Regions | Selected Exons Only |
| Clinical Reporting | ACMG/AMP 2026 Variant Classification + Clinical Correlation Note | Basic Variant Call Without Clinical Context |
Physician Insight & Safety Protocol — بروتوكول السلامة والإشراف الطبي
Clinical Note from Dr. PRABHAKAR REDDY (DHA License: 61713011):
"The KLF8 NGS test is a powerful tool for identifying underlying genetic aetiology in patients presenting with unexplained intellectual disability; however, a negative result does not exclude other genetic or environmental causes. I strongly recommend that every patient undergo pre-test and post-test genetic counselling to interpret results within the full clinical context. Clinical correlation with detailed neurodevelopmental history, family pedigree, and imaging findings remains absolutely essential for accurate diagnosis and management planning."
⚠️ MEDICATION NOTICE — تنبيه طبي هام:
Do not discontinue, adjust, or alter any prescribed medication, anticonvulsant, or neurodevelopmental therapy without consulting your treating physician. This genetic test is diagnostic in nature and does not provide pharmacogenomic guidance for medication management. Any change in treatment must be supervised by your DHA-licensed neurologist or paediatrician.
🚨 Safety Exclusion Criteria & Emergency Red Flags — معايير الاستبعاد وعلامات الطوارئ
- Exclusion: Individuals unable to provide informed consent (or lacking a legal guardian per UAE CDS Law 2026 for minors). Mandatory genetic counselling session required before sample collection.
- Exclusion: Samples received without completed Clinical History & Pedigree Chart documentation as mandated by Federal Decree-Law No. 41 of 2024 (Art. 87).
- Exclusion: Degraded, haemolysed, or improperly stored DNA specimens. Only whole blood in EDTA vacutainers, FTA card dried blood spots, or previously extracted high-quality DNA (A260/A280 ratio 1.8–2.0) are accepted.
- ER Red Flag: If the patient experiences acute neurological deterioration, seizures, or loss of consciousness, proceed immediately to the nearest DHA-licensed Emergency Department. Do not wait for genetic test results.
- ER Red Flag: Test results indicating a pathogenic KLF8 variant should prompt urgent referral to a Clinical Geneticist and Paediatric Neurologist for multidisciplinary management — this does not constitute a medical emergency but requires timely specialist intervention.
Patient FAQ & Clinical Guidance — الأسئلة الشائعة والتوجيهات السريرية
Q1: What does the KLF8 Genetic Test diagnose, and who should consider it?
Snippet: This test identifies pathogenic mutations in the KLF8 gene linked to autosomal non-syndromic intellectual disability, recommended for children or adults presenting with unexplained developmental delay.
The KLF8 Genetic Test is clinically indicated for individuals exhibiting global developmental delay, moderate-to-severe intellectual disability without dysmorphic features, or a family history suggestive of autosomal recessive neurocognitive impairment. It is also appropriate for carrier screening in consanguineous families planning pregnancy, in line with UAE genetic counselling guidelines. A DHA-licensed Neurologist, Clinical Geneticist, or Paediatrician should order this test following comprehensive clinical evaluation.
باختصار: يحدد هذا التحليل الطفرات المسببة للمرض في جين KLF8 المرتبط بالتخلف العقلي غير المتلازمي، ويُنصح به للأطفال أو البالغين الذين يعانون من تأخر نمو غير مفسر سريريًا.
Q2: How is the sample collected, and what preparation is required?
Snippet: A simple blood draw or dried blood spot on an FTA card is collected by a DHA-licensed phlebotomist during home or clinic visit, requiring no fasting or medication changes.
Sample collection options include: (1) Whole Blood — 3–5 mL drawn into an EDTA (lavender-top) vacutainer via standard venipuncture; (2) Dried Blood Spot — one drop of capillary blood applied to an FTA card; or (3) Previously Extracted DNA — high-integrity genomic DNA submitted in a sterile nuclease-free tube. Pre-test requirements mandate a completed genetic counselling session with a detailed three-generation pedigree chart and clinical history documentation. No fasting, dietary restriction, or medication adjustment is necessary for DNA-based NGS testing. Our ISO-certified cold-chain logistics team performs home collection daily from 8 AM to 11 PM across all seven Emirates.
باختصار: تُجمع العينة بسحب دم بسيط أو بقعة دم على بطاقة FTA عبر ممرض مرخص من هيئة الصحة بدبي، دون الحاجة للصيام أو تغيير الأدوية.
Q3: How reliable are the results, and what happens after I receive them?
Snippet: Results are 99.9% analytically accurate with ACMG/AMP 2026 variant classification, followed by a complimentary telephonic clinical correlation session with a DHA-licensed consultant within 48 hours.
All KLF8 Genetic Test results are processed in our ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139) under rigorous quality control. Each report includes: (i) the detected variant(s) classified per ACMG/AMP 2026 guidelines (Pathogenic, Likely Pathogenic, Variant of Uncertain Significance, Likely Benign, or Benign); (ii) zygosity status; (iii) a clinical correlation interpretation; and (iv) recommendations for family cascade screening where applicable. Within 48 hours of report release, a DHA-licensed genetic counsellor or neurologist will conduct a telephonic session to explain findings, answer questions, and guide next steps — including specialist referrals and family planning implications. Your data is protected under UAE PDPL (Personal Data Protection Law) with end-to-end encryption and secure bio-repository storage protocols.
باختصار: النتائج دقيقة بنسبة ٩٩.٩٪ وفق تصنيف ACMG/AMP ٢٠٢٦، تليها استشارة هاتفية مجانية مع استشاري مرخص من هيئة الصحة بدبي خلال ٤٨ ساعة.
UAE Regulatory Compliance & Accreditation — الامتثال التنظيمي والاعتماد
- Federal Decree-Law No. 41 of 2024 (Art. 87): Mandatory pre- genetic counselling and informed consent for all genetic diagnostic procedures.
- CDS Law 2026 (Minors Protection): Genetic testing of minors requires documented parental/guardian consent with clinical justification from a DHA-licensed paediatric neurologist or clinical geneticist.
- UAE PDPL (Personal Data Protection Law): All genomic data is classified as sensitive personal data; stored, processed, and transferred in full compliance with UAE federal data sovereignty requirements.
- ISO 9001:2015 Certification: Facility License No. 9834453 | ISO Cert: INT/EGQ/2509DA/3139 — awarded for quality management systems in medical laboratory operations.
- DHA Facility License: 9834453 — Dubai Health Authority licensed diagnostic facility.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians